bpc 157 what is it uses benefits risks scientific evidence BPC-157 and How Can Benefit You? FDA advisory committee votes to

It is time for self-care

Medication-Based Pain Relief We use evidence-based pharmacological approaches, including anticonvulsants (gabapentin, pregabalin), antidepressants (amitriptyline, duloxetine), and topical treatments (lidocaine patches, capsaicin cream) to alleviate pain

In animal studies, AOD-9604 reduced body weight gain by over 50% in obese mice during a 19-day treatment period, and significantly increased fat oxidation all without affecting insulin sensitivity or glucose regulation.[1,3] A randomized controlled trial in humans found that participants taking 1 mg of AOD-9604 daily lost an average of 2.8 kg (~6 lbs) over 23 weeks, compared to 0.8 kg (~1.7 lbs) in the placebo group

A Change.org petition on that very subject recently garnered more than 100,000 signatures, reflecting the groundswell of support for the motion